文献速递血液净化与透析慢性肾脏病

透析患者CKD相关瘙痒负担与不良临床结局:SCREAM项目

Burden of CKD-Associated Pruritus and Adverse Clinical Outcomes in Patients Receiving Dialysis: The Stockholm Creatinine Measurements (SCREAM) Project.
PubMed 文献 · Am J Kidney Dis · 2024-07-26

基于瑞典斯德哥尔摩2005-2021年3281例维持性透析患者的观察性研究,14%入组时已有瘙痒,中位随访3.3年间19%新发瘙痒。瘙痒与睡眠障碍、焦虑/抑郁及严重感染住院风险升高相关,但与全因死亡无显著关联。

要点

  • 透析患者中至少三分之一在治疗早期出现瘙痒。
  • 瘙痒与睡眠障碍、焦虑/抑郁及严重感染住院风险独立相关。
  • 未发现瘙痒与全因死亡存在可检测的关联。

核心结论

  • 透析患者瘙痒负担高,且与睡眠障碍、焦虑/抑郁和严重感染住院风险升高相关,但与全因死亡无显著关联。

研究设计与样本

  • 观察性研究,纳入2005-2021年瑞典斯德哥尔摩所有维持性透析患者3281例,中位年龄64岁,66%为男性,69%接受血液透析,77%为 incident 透析。

主要发现

  • 入组时456例(14%)存在瘙痒,中位随访3.3年(IQR 1.3-9.2)期间另有539例(19%)发生瘙痒。
  • 年龄较大、女性、较低血清白蛋白及较高C反应蛋白、血清钙、磷水平与瘙痒独立相关。
  • 瘙痒患者睡眠障碍风险升高(校正HR 1.96,95%CI 1.60-2.39),焦虑/抑郁风险升高(校正HR 1.56,95%CI 1.23-1.98),严重感染住院风险升高(校正HR 1.36,95%CI 1.18-1.57)。
  • 严重感染住院风险升高主要归因于脓毒症和腹膜透析相关腹膜炎风险增加。
  • 未检测到瘙痒发生与全因死亡之间的关联。

临床怎么用

  • 透析患者应常规评估瘙痒,尤其对高龄、女性、低白蛋白及高CRP、高钙、高磷者。
  • 对瘙痒患者需关注睡眠障碍、焦虑/抑郁及严重感染风险,加强相应筛查与管理。

局限性

  • 瘙痒若未被临床识别可能存在错分偏倚。
  • 缺乏瘙痒强度/严重程度信息。
  • 暴露和结局诊断均基于诊断编码。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Pruritus is a common but not well-characterized complaint of patients receiving maintenance dialysis. This study sought to quantify the burden of pruritus and its associated adverse health outcomes in this population. STUDY DESIGN: Observational study. SETTING & PARTICIPANTS: All patients receiving maintenance dialysis in Stockholm, Sweden, during 2005-2021. EXPOSURE: Clinically recognized pruritus defined using International Classification of Diseases, Tenth Revision codes or a prescription for antipruritus treatments (including UV therapy). OUTCOMES: All-cause mortality, severe infection-related hospitalizations (composite of endocarditis, peritoneal dialysis-related peritonitis, hemodialysis/peritoneal dialysis-related catheter infection, sepsis due to Staphylococcus spp., or skin infection) and incident diagnoses of anxiety/depression and sleep disorders. ANALYTICAL APPROACH: Multivariable logistic regression and cause-specific hazards models to analyze factors associated with prevalent and new-onset pruritus, respectively. Multivariable cause-specific hazards models with time-varying exposure were used to explore the association of prevalent and new-onset pruritus with adverse health outcomes. RESULTS: Among 3,281 dialysis recipients (median age, 64 years; 66% men; 69% receiving hemodialysis, 77% with incident dialysis), 456 (14%) had pruritus at enrollment. During a median follow-up of 3.3 (IQR, 1.3-9.2) years, 539 (19%) additional patients experienced pruritus. Older age, female sex, a lower serum albumin level, and higher C-reactive protein, serum calcium, and phosphorus levels were independently associated with pruritus. Compared with patients without pruritus, patients with pruritus were at a higher risk of sleep disorders (adjusted HR, 1.96; 95% CI, 1.60-2.39), developing anxiety/depression (adjusted HR, 1.56; 95% CI, 1.23-1.98), and being hospitalized for severe infections (adjusted HR, 1.36; 95% CI, 1.18-1.57), the latter attributed to higher risk of sepsis and peritoneal dialysis-related peritonitis. There was no detectable association between the development of pruritus and all-cause mortality. LIMITATIONS: Potential misclassification bias if pruritus is not clinically recognized, lack of information on pruritus intensity/severity, use of diagnostic codes for exposure and outcome diagnoses. CONCLUSIONS: At least one third of patients experience pruritus during their first years undergoing dialysis, and pruritus was consistently associated with adverse health outcomes. PLAIN-LANGUAGE SUMMARY: Pruritus is a common but not well-characterized symptom of patients receiving dialysis. We analyzed data from 3,281 patients receiving maintenance hemodialysis or peritoneal dialysis in the region of Stockholm, Sweden. At baseline, 14% of patients had pruritus, and pruritus developed in an additional 19% of patients during their time receiving dialysis. We identified conditions associated with the development of pruritus (eg, older age, female sex, lower serum albumin level, and higher C-reactive protein, serum calcium, and phosphorus levels) and observed that the presence of pruritus was associated with higher risks of sleep disorders, developing anxiety and depression, and being hospitalized for severe infections. No association between pruritus and all-cause mortality was identified.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Faucon AL, Clase CM, Rydell H, et al. Burden of CKD-Associated Pruritus and Adverse Clinical Outcomes in Patients Receiving Dialysis: The Stockholm Creatinine Measurements (SCREAM) Project. Am J Kidney Dis. 2024. PMID: 39067660. doi:10.1053/j.ajkd.2024.05.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。